Intrapleural Fibrinolytic Therapy for Empyema and Pleural Loculation: Knowns and Unknowns.
作者信息
Idell Steven, Rahman Najib M
机构信息
1 The Department of Cellular and Molecular Biology and the Texas Lung Injury Institute, the University of Texas Health Science Center at Tyler, Tyler, Texas.
2 Oxford Pleural Unit and Oxford Respiratory Trials Unit, University of Oxford, Churchill Hospital, Oxford, United Kingdom; and.
出版信息
Ann Am Thorac Soc. 2018 May;15(5):515-517. doi: 10.1513/AnnalsATS.201711-848PS.
Abstract
摘要
相似文献
1
Intrapleural Fibrinolytic Therapy for Empyema and Pleural Loculation: Knowns and Unknowns.
Ann Am Thorac Soc. 2018 May;15(5):515-517. doi: 10.1513/AnnalsATS.201711-848PS.
2
Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema.
Cochrane Database Syst Rev. 2008 Apr 16(2):CD002312. doi: 10.1002/14651858.CD002312.pub3.
3
Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema.
Cochrane Database Syst Rev. 2004(2):CD002312. doi: 10.1002/14651858.CD002312.pub2.
4
Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials.
Clin Respir J. 2014 Jul;8(3):281-91. doi: 10.1111/crj.12068. Epub 2014 Jan 16.
5
Intra-pleural fibrinolytic therapy vs. conservative management in the treatment of parapneumonic effusions and empyema.
Cochrane Database Syst Rev. 2000(3):CD002312. doi: 10.1002/14651858.CD002312.
6
Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.
Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD002312. doi: 10.1002/14651858.CD002312.pub4.
7
Intrapleural streptokinase for the treatment of complicated parapneumonic effusion and empyema in 2 newborns.
J Pediatr Surg. 2012 Oct;47(10):e41-4. doi: 10.1016/j.jpedsurg.2012.07.034.
8
Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema.
Acta Med Indones. 2012 Jul;44(3):258-64.
9
Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: a meta-analysis.
Chest. 2006 Mar;129(3):783-90. doi: 10.1378/chest.129.3.783.
10
Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema.
Chest. 2018 Sep;154(3):550-556. doi: 10.1016/j.chest.2018.01.037. Epub 2018 Feb 6.
引用本文的文献
1
Research Priorities for Malignant Pleural Organization with Loculation and Failed Drainage.
Cells. 2025 Jul 21;14(14):1118. doi: 10.3390/cells14141118.
2
Intrapleural Fibrinolytic Interventions for Retained Hemothoraces in Rabbits.
Int J Mol Sci. 2024 Aug 12;25(16):8778. doi: 10.3390/ijms25168778.
3
A Novel Rabbit Model of Retained Hemothorax with Pleural Organization.
Int J Mol Sci. 2023 Dec 29;25(1):470. doi: 10.3390/ijms25010470.
4
Targeting the PAI-1 Mechanism with a Small Peptide Increases the Efficacy of Alteplase in a Rabbit Model of Chronic Empyema.
Pharmaceutics. 2023 May 14;15(5):1498. doi: 10.3390/pharmaceutics15051498.
5
Is the Urokinase Plasminogen Activator/Plasminogen Activator Inhibitor-1 Ratio a Marker of Sonographic Septations in Pleural Infection?
Am J Respir Crit Care Med. 2023 Apr 1;207(7):949. doi: 10.1164/rccm.202210-1916LE.
6
PAI-1 Drives Septation and Clinical Outcomes in Pleural Infection.
Am J Respir Crit Care Med. 2023 Mar 15;207(6):653-655. doi: 10.1164/rccm.202210-1925ED.
7
A Comparative Study of the Safety and Efficacy of Intrapleural Fibrinolysis With Streptokinase and Urokinase in the Management of Loculated Pleural Effusions.
Cureus. 2022 Jun 24;14(6):e26271. doi: 10.7759/cureus.26271. eCollection 2022 Jun.
8
Update on Novel Targeted Therapy for Pleural Organization and Fibrosis.
Int J Mol Sci. 2022 Jan 29;23(3):1587. doi: 10.3390/ijms23031587.
9
From Bedside to the Bench-A Call for Novel Approaches to Prognostic Evaluation and Treatment of Empyema.
Front Pharmacol. 2022 Jan 20;12:806393. doi: 10.3389/fphar.2021.806393. eCollection 2021.
10
Intrapleural use of urokinase and DNase in pleural infections managed with repeated thoracentesis: A comparative cohort study.
PLoS One. 2021 Sep 21;16(9):e0257339. doi: 10.1371/journal.pone.0257339. eCollection 2021.
本文引用的文献
1
Dose De-escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection. The Alteplase Dose Assessment for Pleural Infection Therapy Project.
Ann Am Thorac Soc. 2017 Jun;14(6):929-936. doi: 10.1513/AnnalsATS.201609-673OC.
2
Surgical versus non-surgical management for pleural empyema.
Cochrane Database Syst Rev. 2017 Mar 17;3(3):CD010651. doi: 10.1002/14651858.CD010651.pub2.
3
Streptokinase Treatment Reverses Biofilm-Associated Antibiotic Resistance in Staphylococcus aureus.
Microorganisms. 2016 Sep 20;4(3):36. doi: 10.3390/microorganisms4030036.
4
Dose dependency of outcomes of intrapleural fibrinolytic therapy in new rabbit empyema models.
Am J Physiol Lung Cell Mol Physiol. 2016 Aug 1;311(2):L389-99. doi: 10.1152/ajplung.00171.2016. Epub 2016 Jun 24.
5
The time course of resolution of adhesions during fibrinolytic therapy in tetracycline-induced pleural injury in rabbits.
Am J Physiol Lung Cell Mol Physiol. 2015 Sep 15;309(6):L562-72. doi: 10.1152/ajplung.00136.2015. Epub 2015 Jul 10.
6
Pleural irrigation trial (PIT): a randomised controlled trial of pleural irrigation with normal saline versus standard care in patients with pleural infection.
Eur Respir J. 2015 Aug;46(2):456-63. doi: 10.1183/09031936.00147214. Epub 2015 May 28.
7
Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery.
Ann Am Thorac Soc. 2014 Nov;11(9):1419-25. doi: 10.1513/AnnalsATS.201407-329OC.
8
Plasminogen-plasmin system in the pathogenesis and treatment of lung and pleural injury.
Semin Thromb Hemost. 2013 Jun;39(4):373-81. doi: 10.1055/s-0033-1334486. Epub 2013 Mar 16.
9
New therapeutic approaches to pleural infection.
Curr Opin Infect Dis. 2013 Apr;26(2):196-202. doi: 10.1097/QCO.0b013e32835d0b71.
10
Intrapleural adenoviral delivery of human plasminogen activator inhibitor-1 exacerbates tetracycline-induced pleural injury in rabbits.
Am J Respir Cell Mol Biol. 2013 Jan;48(1):44-52. doi: 10.1165/rcmb.2012-0183OC. Epub 2012 Sep 20.
Zotero 插件